Herbalife (HLF) to Announce Earnings on Wednesday

Herbalife (NYSE:HLF) is expected to release its Q2 2026 results after the market closes on Wednesday, August 5th. Analysts expect the company to post earnings of $0.5360 per share and revenue of $1.3076 billion for the quarter. Investors can find conference call details on the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Wednesday, August 5, 2026 at 5:30 PM ET.

Herbalife (NYSE:HLF) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $0.64 earnings per share for the quarter, beating analysts’ consensus estimates of $0.61 by $0.03. Herbalife had a negative return on equity of 41.47% and a net margin of 4.67%.The firm had revenue of $1.32 billion during the quarter, compared to the consensus estimate of $1.30 billion. During the same period last year, the company earned $0.59 earnings per share. The business’s revenue was up 7.8% compared to the same quarter last year. On average, analysts expect Herbalife to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Herbalife Stock Up 2.4%

Shares of Herbalife stock opened at $12.72 on Tuesday. Herbalife has a 12-month low of $7.56 and a 12-month high of $20.40. The stock has a market cap of $1.32 billion, a P/E ratio of 5.58, a P/E/G ratio of 0.68 and a beta of 0.87. The business’s 50 day moving average is $12.26 and its 200-day moving average is $14.62.

Analysts Set New Price Targets

A number of brokerages recently weighed in on HLF. Mizuho set a $17.00 target price on shares of Herbalife in a report on Monday, May 4th. Wall Street Zen cut shares of Herbalife from a “strong-buy” rating to a “buy” rating in a research note on Saturday, July 18th. Royal Bank Of Canada decreased their price objective on shares of Herbalife from $17.00 to $16.00 and set a “sector perform” rating for the company in a research report on Tuesday, April 28th. Zacks Research cut shares of Herbalife from a “strong-buy” rating to a “hold” rating in a report on Monday, April 20th. Finally, Weiss Ratings downgraded shares of Herbalife from a “hold (c+)” rating to a “hold (c)” rating in a research note on Friday, July 24th. Three research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Herbalife presently has an average rating of “Hold” and an average target price of $17.80.

Insider Buying and Selling at Herbalife

In other news, insider Frank Lamberti sold 134,982 shares of the stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $13.50, for a total value of $1,822,257.00. Following the transaction, the insider directly owned 36,624 shares of the company’s stock, valued at $494,424. This represents a 78.66% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Troy Hicks sold 38,377 shares of the firm’s stock in a transaction dated Monday, May 18th. The stock was sold at an average price of $12.93, for a total transaction of $496,214.61. Following the sale, the chief operating officer owned 9,062 shares of the company’s stock, valued at approximately $117,171.66. This represents a 80.90% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 191,296 shares of company stock worth $2,551,678. Corporate insiders own 5.13% of the company’s stock.

Institutional Investors Weigh In On Herbalife

Hedge funds have recently bought and sold shares of the stock. AQR Capital Management LLC grew its position in shares of Herbalife by 236.8% in the first quarter. AQR Capital Management LLC now owns 133,245 shares of the company’s stock valued at $1,150,000 after purchasing an additional 93,686 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Herbalife by 4.4% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 59,964 shares of the company’s stock worth $517,000 after purchasing an additional 2,523 shares during the last quarter. Empowered Funds LLC boosted its stake in Herbalife by 12.9% in the 1st quarter. Empowered Funds LLC now owns 30,301 shares of the company’s stock valued at $261,000 after purchasing an additional 3,474 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in Herbalife by 3.3% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 210,904 shares of the company’s stock valued at $1,820,000 after purchasing an additional 6,747 shares during the period. Finally, Envestnet Asset Management Inc. acquired a new position in Herbalife in the 2nd quarter valued at $118,000.

Herbalife Company Profile

Herbalife Nutrition Ltd. (NYSE: HLF) operates as a global multi-level marketing company specializing in weight-management, nutritional supplement, sports nutrition and personal care products. Its portfolio includes protein shakes, vitamins, energy and fitness supplements, hydration products and skin and hair care items, all formulated to support wellness, performance and healthy living. Products are manufactured in GMP-certified facilities to ensure consistent quality and safety standards.

Founded in 1980 by Mark R.